BIOVECTRA To Be Sold for C$1.3B

BIOVECTRA, the Charlottetown drug maker that in 2019 was bought by Miami-based H.I.G. Capital for US$250 million, has reached an agreement to be sold again, this time for US$925 million or C$1.27 billion.
The deal with Santa Clara, California’s Agilent Technologies is expected to close by the end of this year, BIOVECTRA said in a statement. The companies did not disclose the conditions that must